rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Narinder Pal Bhalla

Chief Medical Officer

Company insider

Files Form 4 as: Chief Medical Officer, Lexeo Therapeutics.

Every Form 4 they filed

In numbers

Trades disclosed
12
Buys
0
Sells
1
Bought
$0
Sold
$197K
Companies
1
Companies where not an officer
0
First trade
13 Feb 2026
Last trade
24 Sep 2026
Last filed
28 Sep 2026

Companies traded

Where they are an officer
LXEO Lexeo TherapeuticsOfficer · Biotechnology · last 24 Sep 20260 buys · 1 sell

Activity over time

1 Jun – 1 Oct
10Jun 26Jul 26Aug 26Sep 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
24 Sep 2026filed 28 Sep 2026LXEO Lexeo Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—54,750 at $0.00filing
24 Sep 2026filed 28 Sep 2026LXEO Lexeo Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—54,750 at $0.00filing
14 Sep 2026filed 28 Sep 2026LXEO Lexeo TherapeuticsBiotechnologySEC FORM 4 Code A$9,7132,714 at $3.58filing
14 Sep 2026filed 28 Sep 2026LXEO Lexeo TherapeuticsBiotechnologySEC FORM 4 Code A$9,7162,714 at $3.58filing
1 Jul 2026filed 1 Jul 2026LXEO Lexeo TherapeuticsBiotechnologySEC FORM 4 Sold$99K22,306 at $4.42filing
1 Jul 2026filed 1 Jul 2026LXEO Lexeo TherapeuticsBiotechnologySEC FORM 4 Sold$99K22,306 at $4.42filing
29 Jun 2026filed 1 Jul 2026LXEO Lexeo TherapeuticsBiotechnologySEC FORM 4 Code A—55,000 at $0.00filing
29 Jun 2026filed 1 Jul 2026LXEO Lexeo TherapeuticsBiotechnologySEC FORM 4 Code A—55,000 at $0.00filing
13 Feb 2026filed 17 Feb 2026LXEO Lexeo TherapeuticsBiotechnologySEC FORM 4 Code A—49,500 at $0.00filing
13 Feb 2026filed 17 Feb 2026LXEO Lexeo Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—297,000 at $0.00filing
13 Feb 2026filed 17 Feb 2026LXEO Lexeo Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—297,000 at $0.00filing
13 Feb 2026filed 17 Feb 2026LXEO Lexeo TherapeuticsBiotechnologySEC FORM 4 Code A—49,500 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care1

Buys in green, sells in red, by the company’s sector.

Related people

Louis Edward TamayoChief Financial Officer · Chief Financial Officer at Lexeo Therapeutics, filing Form 4 there in the last year
Jose Manuel OteroChief Operating Officer · Chief Operating Officer at Lexeo Therapeutics, filing Form 4 there in the last year
Richard Nolan TownsendChief Executive Officer · Chief Executive Officer at Lexeo Therapeutics, filing Form 4 there in the last year
Mette Kirstine AggerDirector · Director at Lexeo Therapeutics, filing Form 4 there in the last year
Timothy Van HauwermeirenDirector · Director at Lexeo Therapeutics, filing Form 4 there in the last year